Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
21
|
pubmed:dateCreated |
1967-9-3
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0025-729X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1086-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6028343-Adult,
pubmed-meshheading:6028343-Aged,
pubmed-meshheading:6028343-Female,
pubmed-meshheading:6028343-Humans,
pubmed-meshheading:6028343-Male,
pubmed-meshheading:6028343-Middle Aged,
pubmed-meshheading:6028343-Parasympatholytics,
pubmed-meshheading:6028343-Parkinson Disease
|
pubmed:year |
1967
|
pubmed:articleTitle |
A comparative study of "UCB 1549" and "SD 25" in the treatment of Parkinson's disease.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|